Summary:
Randomized, double-blinded, placebo controlled trial of adjunctive troriluzole in Obsessive compulsive disorder
Qualified Participants Must:
• Diagnosis of obsessive compulsive disorder for 1 yr
•
Be on treatment for OCD for 8 weeks
•
18-65 years old
•
No diagnosis of bipolar
Qualified Participants May Receive:
compensation for time and travel
transporation available for all patients